TRIALSITEIQ PUBLIC FEASIBILITY SCORECARD · GRADE C

NCT07907055: PROSPECTIVE MULTICENTER STUDY OF THE SAFETY AND EFFECTIVENESS OF THE PAUL® GLAUCOMA IMPLANT

Sponsor: Clinical Research Consultants, Inc. · Phase: PHASE2 · Area: CARDIOLOGY_METABOLIC · Target Enrollment: 65 pts

Competing Trials Overlap

2 Active Trials

Excess Burn Exposure

$10,624,000

Rescue Site Savings

+$7,005,200

Unlock Full NCT07907055 Backup Super-Site Packet ($49 One-Time Pass)

Download the complete list of top-decile low-cannibalization clinical sites, verified Principal Investigator (PI) direct emails/phones, and protocol optimization benchmarks.

Download $49 NCT07907055 Rescue Dossier →